Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVARIAN
2024-511720-13-00Phase 3Authorised
- Sponsor
- CHRU Nancy
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of sulfur hexafluoride in adnexal torsion (2 arms), sponsored by CHRU Nancy. Primary endpoint: Percentage of emergency surgeries without proven adnexal torsion. Planned start Oct 2024; status: authorised.
02
Drugs
sulfur hexafluoride
03
Conditions
adnexal torsion
Beyond the preview
Go deeper on 2024-511720-13-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511720-13-00.